Guru Ownership Trend
Guru Analysis for Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. (KYMR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $14.53 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2,645.51 net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 8.3%. Conversely, Steven Cohen reduced exposure by 0.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Kymera Therapeutics, Inc. (KYMR)
Major holders include Steven Cohen ($13.47 M), Cliff Asness ($726,668). According to the latest reported data, 2 tracked investment managers collectively hold approximately 182,486 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2,645.51, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited KYMR. The total reported sell value was $58,590.93.
Yes, 0 managers opened new positions in KYMR, and 1 increased their existing holdings. The total reported buy value was $55,945.42.